𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Long-term titrated recombinant interferon-α2a in chronic hepatitis C: a randomized controlled trial

✍ Scribed by M. G. Rumi; E. Del Ninno; M. L. Parravicini; R. Romeo; R. Soffredini; M. F. Donate; F. Zahm; M. Colombo

Book ID
119836534
Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
293 KB
Volume
2
Category
Article
ISSN
1352-0504

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High doses of recombinant α-interferon o
High doses of recombinant α-interferon or γ-interferon for chronic hepatitis C: A randomized, controlled trial
✍ Federico Sáez-royuela; Juan Carlos Porres; Alberto Moreno; Inmaculada Castillo; 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 438 KB

Chronic hepatitis C is often a progressive liver disease for which there is no satisfactory treatment. We studied the efficacy of recombinant a-interferon or y-interferon in the treatment of this disease in comparison with a control group. Thirty patients were randomly assigned to three groups. Ten

Treatment of chronic hepatitis C with re
Treatment of chronic hepatitis C with recombinant human interferon-α2a: Results of a randomized controlled clinical trial
✍ Giulio Diodati; Paola Bonetti; Franco Noventa; Carla Casarin; Massimo Rugge; Ser 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 506 KB

Sixty consecutive patients with chronic hepatitis C were included in a randomized controlled trial of recombinant human interferon-%, vs. no treatment. Treated patients received tapering doses of interferon thrice weekly for 1 yr. Twenty treated cases (66.7%) normalized serum aminotransferase levels